MBBS, MRCP(UK), FRCP(London), FRCP(Edin)
19 years of experience
Headington, OX3 7RP
(+2 more)
22 connections in healthcare
Skill endorsed
by Dr. Arif Hussenbux
19 years of experience
Headington, OX3 7RP
(+2 more)
22 connections in healthcare
Skill endorsed
by Dr. Arif Hussenbux
Areas of expertise
Contact
Book
Dr Udit Mittal MBBS, MRCP(UK), FRCP(London), FRCP(Edin) is a leading Consultant Gastroenterologist, and nationally accredited bowel‑cancer‑screening colonoscopist at Oxford University Hospitals. With thousands of procedures performed, he offers specialist diagnosis and management for a comprehensive range of digestive and liver disorders. His practice covers heartburn and acid reflux (gastro‑oesophageal reflux disease and GORD), indigestion (dyspepsia), swallowing difficulties (dysphagia), abdominal pain, bloating, diarrhoea, constipation, irritable bowel syndrome (IBS), irritable bowel disorders, coeliac disease and food intolerances, inflammatory bowel disease (Crohn’s disease and ulcerative colitis), rectal bleeding, haemorrhoids, gallstones, diverticular disease, diverticulitis, Barrett’s oesophagus, microscopic colitis, colon polyps and colorectal cancer screening, as well as nutritional and immune‑related conditions such as iron‑deficiency anaemia, autoimmune gastritis, haemochromatosis and malabsorption syndromes. He manages liver and pancreaticobiliary disease including fatty liver, cirrhosis, jaundice, pancreatitis, gallbladder polyps and gallstones, and offers expertise in gut‑microbiome imbalances (SIBO and dysbiosis), functional bowel disease, bloating, nausea and vomiting, unexplained weight loss and food intolerance.
Dr Mittal graduated in 2006, completed internal medicine training in Sheffield, and specialised in gastroenterology and advanced endoscopy in Oxford. He was appointed Consultant Gastroenterologist at the John Radcliffe Hospital, where he developed a reputation for meticulous, compassionate care. As a nationally accredited bowel cancer screening colonoscopist, he performs a very high volume of diagnostic and therapeutic endoscopic procedures, including gastroscopy (OGD), colonoscopy, flexible sigmoidoscopy, polypectomy and advanced endoscopic mucosal resection (EMR). His focus is on early detection, precision diagnostics and prevention to reduce the risk of cancer and serious gastrointestinal disease.
A champion of patient‑centred care, Dr Mittal offers private endoscopy and colonoscopy with sedation at The Manor Hospital in Oxford, The New Foscote Hospital in Banbury and the Royal Buckinghamshire Hospital in Aylesbury. He provides face‑to‑face, video and telephone consultations for both insured and self‑funding patients, with appointments available in the evenings to accommodate busy schedules. Consultations can be booked without GP referral and he is registered with all major insurers, including Bupa, AXA, Aviva, WPA, Vitality, Cigna, Aetna and Allianz.
Beyond clinical practice, Dr Mittal is the Regional Representative for Oxfordshire on the British Society of Gastroenterology’s Clinical Services and Standards Committee and a Regional Specialty Adviser for the Royal College of Physicians (London). He represents Oxford and Thames Valley on the RCP’s New Consultant Committee and is a Fellow of the Royal Colleges of Physicians of London and Edinburgh. He maintains a strong interest in precision medicine, preventative gastroenterology, the gut microbiome and digital health, regularly contributing to research and professional development. Dr Mittal speaks English and Hindi, and is known for his clear, empathetic communication and thorough follow‑up.
Services
Why choose Dr Mittal?
– Leading bowel‑cancer‑screening colonoscopist: accredited by the National Bowel Cancer Screening Programme and performing high volumes of procedures with excellent safety records.
– Extensive expertise: manages the full spectrum of gastrointestinal, liver, pancreatic and nutritional conditions using the latest evidence and technology.
– Precision and prevention focus: emphasises early detection, precision diagnostics, minimally invasive interventions and personalised treatment plans.
– Leadership and credentials: Regional Representative for Oxfordshire (BSG) and Regional Specialty Adviser for the RCP; Fellow of the Royal Colleges of Physicians.
– Patient‑centred care: known for attentive listening, clear explanations, empathetic approach and thorough follow‑up; offers flexible appointment options (in‑person, video, telephone).
– Convenient locations and multilingual service: consultations and procedures in Oxford, Banbury and Aylesbury; speaks English and Hindi, welcoming insured and self‑funding patients.
Click the bar to read reviews or skill endorsements
General Medical Council
No. 7120397
Dr. Bhim Rao Abdekar University
Medicine
Graduated 2006
New appointment
£300Follow-up appointment
£225Beech Road, Headington, United Kingdom, OX3 7RP
2 Foscote Rise, Banbury, United Kingdom, OX16 9XP
Buckingham Road, Aylesbury, United Kingdom, HP19 9AB
Areas of expertise
Contact
Book
This summary was created by AI based on recent reviews
Dr. Udit Mittal is kind, caring, professional, clear, and thorough with patients. He makes camera procedures easy and relaxing. He explains issues well, listens to worries, and gives good advice. Patients value his skill and feel sure about care for stomach pain.
Just such a lovely kind man who was very reassuring and professional in all respects
Dr. Mittal is highly professional, exceptionally polite, and demonstrates genuine care for his patients.
I saw Dr Mittal and his team at The Foscote Hospital and underwent a Gastroscopy... I was treated with respect and kindness from when I walked through the door ... I have had this procedure before a few times but can honestly say this was the best experience. I had the throat numbing spray plus sedation. I would recommend Dr. Mittal to anyone having the same procedure.
Dr Udit Mittal was professional, friendly and reassuring. He had a really calm manner which is what I needed as I was so anxious about the situation. From my first consultation, my procedures to my final consultation I felt informed and cared for, highly recommend.
I would wholeheartedly recommend Dr Mittal. He is thorough, clear, accessible, sympathetic and understanding. He is an exceptional doctor in my opinion.
100%. Dr Mittal is unbelieveable in his total commitment. A true professional in all aspects of his work. Leaves no stone unturned.
Dr Mittal is patient and willing to answer questions, in fact he encourages questions to be made. The appointments with him doesn't feel rushed.
I recently had a camera uo and down and the whole experience was made simple by Dr Mittal.
Dr Mittal has been absolutely amazing throughout my treatment plan. He has been thorough with his assessments and a kind and caring manner. He explains everything so clearly and has enabled me to get my life back with the correct medication. I cannot recommend him highly enough. Thank you Dr Mittal.
Compassionate and caring clinician. Skilled endoscopist and a valued colleague who I have no hesitation referring to.
04 Sep 2025
Dr. Arif Hussenbux
GastroenterologistExplore videos from Dr. Udit Mittal explaining process of procedures and other important things you should know before choosing your provider.
🧠 IBS is real — but many patients still feel they have to prove it. In clinic, I often meet patients who have spent months or years feeling dismissed because their scans, blood tests or endoscopy have not shown a clear structural disease. But “normal tests” do not mean “nothing is wrong”. The updated Rome V framework describes IBS and related bowel disorders as part of a group called disorders of gut–brain interaction. These conditions can involve abdominal pain or discomfort, bloating, distension, constipation, diarrhoea, or a mixture of bowel symptoms. Rome V classifies bowel disorders into IBS, chronic constipation, functional diarrhoea, functional abdominal bloating, unclassified bowel disorder, and opioid-induced constipation. One of the most important messages is that IBS should be diagnosed positively and confidently — not as a vague “we could not find anything else” label. That does not mean ignoring red flags. Symptoms such as rectal bleeding, anaemia, unexplained weight loss, nocturnal diarrhoea, new symptoms after the age of 50, or a strong family history of bowel cancer, inflammatory bowel disease or coeliac disease should prompt appropriate assessment. But when the history fits, red flags are absent, and targeted tests are reassuring, patients deserve a clear explanation: IBS can involve altered gut sensitivity, bowel motility, immune activation, microbiome changes, diet-related triggers, stress physiology, and gut–brain signalling. That explanation matters. Because saying “nothing is wrong” can feel dismissive. Saying “your gut is more sensitive and reactive, and we have ways to help” can be validating, reassuring, and therapeutic. Treatment is not one-size-fits-all. It may include dietary strategies, soluble fibre, laxatives, anti-diarrhoeal treatment, antispasmodics, bile acid binders, neuromodulators, gut-directed psychological therapies, or a combination — depending on the symptom pattern and patient preference. IBS is common. IBS is real. IBS is treatable. And patients deserve to be believed. Nuffield Health The Manor Hospital The New Foscote Hospital The Royal Buckinghamshire Hospital Akessa Healthcare Group Linbury Doctors Concierge Medical Practice #Gastroenterology #IBS #GutHealth #DGBI #FunctionalBowelDisorders #PatientEducation #MedEd
06 June 2026
linkedin.com

If you’re experiencing digestive symptoms, Dr. Udit Mittal, Consultant Gastroenterologist and Endoscopist at The Royal Buckinghamshire Hospital, provides thorough evaluation and tailored management for a wide range of gastrointestinal conditions. Book your consultation with Dr. Udit Mittal today. 📞 Want to learn more or make an enquiry? ➡️ Visit www.royalbucks.co.uk 📧 Email enquiries@royalbucks.co.uk 📱 Or call 01296 678800 to speak with our team #RoyalBuckinghamshireHospital #Gastroenterology #Endoscopy #GutHealth #DigestiveHealth #PrivateHealthcare #Colonoscopy #Gastroscopy #AbdominalPain #PatientCare #Aylesbury #Buckinghamshire #BucksHealthcare".
04 July 2026
instagram.com
Fermentation is not the enemy — but in the wrong gut, at the wrong time, it can feel like one. Many patients tell me: “I eat healthy food — lentils, onions, garlic, fruit, yoghurt, wholegrains — but I feel bloated, windy, distended or uncomfortable.” This is where understandinggut fermentationhelps. Fermentation is a normal process. Bacteria in the gut break down certain carbohydrates and fibres, producing gases and short-chain fatty acids. These short-chain fatty acids, including butyrate, are important for gut health, the gut barrier and immune signalling. So fermentation itself is not “bad”. The problem is that in some people — especially those with disorder of gut–brain interaction — normal fermentation can become symptomatic because of: • increased gas production • water being drawn into the bowel • altered motility • visceral hypersensitivity • a gut that is more sensitive to stretch and distension This is why foods such as onions, garlic, wheat, beans, lentils, some fruits, milk, polyols and certain “healthy” high-fibre foods can trigger bloating, cramps, urgency or loose stools in some people. This is also the basis of thelow-FODMAP diet. But an important point: A low-FODMAP diet is not meant to be a permanent “healthy gut diet”. It is best used as a structured, time-limited diagnostic and therapeutic tool — ideally with dietetic guidance — followed by careful reintroduction and personalisation. The goal is not to remove fermentation forever. The goal is to identify which fermentable carbohydrates your gut struggles with, at what dose, and in what combination — while preserving dietary variety and microbiome health. In clinic, I often explain it like this: The same food can be nourishing for one gut and symptom-provoking for another. That does not mean the food is bad — it means the gut’s handling and sensitivity matter. For persistent bloating, distension, abdominal pain, diarrhoea, constipation or food intolerance symptoms, it is important not to self-diagnose everything as “just fermentation”. Coeliac disease, inflammatory bowel disease, bile acid diarrhoea, pancreatic insufficiency, microscopic colitis, SIBO/IMO and other conditions may need consideration depending on the clinical context. Fermentation is biology. Symptoms are biology plus sensitivity, motility, microbiome, diet pattern and the gut–brain axis. That is why personalised, evidence-based care matters. #Gastroenterology #GutHealth #IBS #Bloating #FODMAP #Microbiome #GutBrainAxis #DigestiveHealth
04 July 2026
linkedin.com
Read articles from Dr. Udit Mittal explaining process of procedures and other important things you should know before choosing your provider.
Colorectal cancer survival — a global snapshot that tells a powerful story The latest 5-year survival rates reveal just how uneven the global landscape remains — and how critical early detection, access to care, and screening programs really are. 🔹 🇰🇷 South Korea – 5-year survival: ~75% (national screening success) 🔹 🇯🇵 Japan – 5-year: ~71%, 10-year: ~60% 🔹 🇸🇬 Singapore – 5-year: ~64% 🔹 🇺🇸 USA – 5-year: ~65%, 10-year: ~58% 🔹 🇬🇧 UK – 5-year: ~58–60%, 10-year: ~55% 🔹 🇨🇳 China – 5-year: ~62% 🔹 🇪🇺 Western Europe – 5-year: ~60–68% 🔹 🇸🇦 Saudi Arabia – 5-year: ~52%, 10-year: ~45% 🔹 🌏 Southeast Asia (Malaysia/Thailand) – 5-year: ~44–51% 🔹 🇮🇳 India – 5-year: ~34–37% 🔍 The stage at diagnosis changes everything: Stage I → ~90% survive 5 years Stage IV → ~10% survive 5 years ✅ Countries with national screening (e.g. FIT, colonoscopy) catch more cancers early. ✅ Early treatment improves survival dramatically. 📈 The good news: survival is improving in many regions. 📉 The concern: in others, like India and parts of Southeast Asia, survival has barely moved in 20+ years. We know what works. The challenge is scale. #ColorectalCancer #Earlydetection #Gastroenterology #CancerAwareness Sources (2020–2025): UK: Cancer Research UK, 2023 USA: SEER (NCI), 2023; ASCO Japan: Nat'l Cancer Center Japan Korea: Korea Central Cancer Registry China: Frontiers in Oncology, 2023 India: ICMR / SurvCan-3 Singapore: Singapore Cancer Registry Saudi Arabia: Saudi Cancer Registry (2009–17) Malaysia/Thailand: MySCan 2020; Thai cancer registries Europe: EUROCARE, OECD, ENCR
19 February 2026
linkedin.com
Colorectal cancer: the same disease — very different chances. Early detection saves lives — for you and the people who love you. ❤️ In 2022, nearly 2 million people worldwide were told they had colorectal cancer. Many more are living with it today thanks to earlier detection — but access isn’t equal. Where screening is routine: 🇬🇧 🇦🇺 🇳🇿 🇯🇵 🇸🇬 🇪🇺 Countries like the UK, Australia, New Zealand, Japan, Singapore and many in Europe invite people for a simple home stool test (FIT) and follow up with colonoscopy — this saves lives. ✅ USA: 🇺🇸 Screening is recommended (45–75) and widely covered, but there’s no single national invite system. South Asia & others: 🇮🇳 🇵🇰 🇧🇩 🇱🇰 🇳🇵 🇧🇹 🇲🇻 🇦🇫 Much of South Asia still lacks national CRC screening. China is running city/high-risk programmes and trials; Malaysia largely uses opportunistic FIT. Why it matters (resources): 💸 High-income countries spend thousands of US$ per person on health each year; across much of South Asia it’s often <$200 — a gap that shows up as later diagnosis and worse outcomes. What helps close the gap? 🧪 Organised, quality-assured screening (FIT invitations + prompt colonoscopy) 🏥 Investment in diagnostics and endoscopy capacity 📣 Public awareness — if you’re 45–75, ask about screening; where invites don’t exist, ask your clinician about FIT References: • WHO–IARC GLOBOCAN (2022) – global & country CRC burden • NHS Bowel Screening (UK) – programme & age range • USPSTF / CDC (USA) – CRC screening recommendation 45–75 • EU Council (2022) – cancer screening recommendation (CRC) • Australia & NZ national programmes – FIT invitation details • Japan & Singapore screening pages – municipal/national FIT programmes • World Bank / WHO GHED – health expenditure per capita #bowelcancer #earlydetection #colorectalcancer
28 February 2026
linkedin.com
🧬 Colorectal Cancer in the Young: A Global Shift While colorectal cancer (CRC) has long been seen as a disease of older adults, a new global pattern is emerging: incidence in adults under 50 is rising — across regions, income levels, and healthcare systems. 📍 United States: CRC in under-50s now accounts for ~19,550 cases annually (2023). The age-standardized incidence rate (ASIR) is ~15 per 100,000 and continues to rise steadily. 📖 Siegel RL et al., CA Cancer J Clin, 2023 📍 United Kingdom: ~2,500 cases yearly in under-50s, with a notable +3.6% annual increase — one of the fastest in Europe. 📖 Sung H et al., Lancet Oncol, 2024 📍 India: An estimated 4,000 early-onset CRC cases annually. ASIR is low (~4/100k), but rising 2–3% per year. 📖 Arora S et al., Indian J Gastroenterol, 2024 📍 China: ~78,700 CRC cases under age 50 in 2021 — the highest global burden. ASIR is ~9.8 per 100,000 and increasing. 📖 Ye Y et al., Sci Rep, 2025 📍 Japan: Estimated 5,000 cases annually in under-50s. ASIR is moderate and trending upward. 📖 Hirayama Y et al., 2025 (in press) 📍 Middle East & Southeast Asia: Thousands of early-onset CRC cases occur each year. ASIRs are currently low to moderate, but regional studies report significant upward trends in countries like Kuwait, Thailand, and Turkey. 📖 Roshandel G et al., Cancers, 2024; Meng X et al., BMC Med, 2025 🧠 Why this matters: Though still a minority of total CRC cases (5–13%), early-onset CRC is rising — often more aggressive and diagnosed later. This calls for earlier awareness, timely diagnostics, and a re-evaluation of age-based screening thresholds globally. 📢 It’s time to talk about CRC risk in the young. #ColorectalCancer #EarlyOnsetCRC #Gastroenterology #CancerScreening #CancerAwareness #PreventiveMedicine References: • Siegel RL et al. CA Cancer J Clin. 2023;73(3):233–254 • Sung H et al. Lancet Oncol. 2024;25(2):125–137 • Ye Y et al. Sci Rep. 2025;15:912 • Arora S et al. Indian J Gastroenterol. 2024;43(1):11–18 • Hirayama Y et al. 2025 (in press) • Roshandel G et al. Cancers. 2024;16(3):621 • Meng X et al. BMC Med. 2025;23:104
07 March 2026
linkedin.com
Has the cancer risk profile in FAP quietly shifted? For decades, Familial Adenomatous Polyposis (FAP) has been synonymous with colorectal cancer risk. However, a 50-year nationwide cohort study from the Netherlands suggests the cancer spectrum may be evolving. Since 2020, gastric cancer has become the most frequently diagnosed cancer in their FAP cohort. Despite major advances in preventing colorectal cancer through surgery and surveillance, individuals with FAP remain at significantly increased risk of multiple malignancies — including: • Gastric cancer (SIR ~12) • Duodenal cancer • Thyroid cancer • CNS tumours This is a substantial shift in long-term risk patterns. The study is available here: 🔗 https://lnkd.in/eF2cDZqm Why this matters clinically Upper GI surveillance may require renewed emphasis — particularly meticulous inspection of the stomach in patients with carpeting fundic gland polyposis, where early neoplastic change can be subtle. FAP is a multisystem cancer predisposition syndrome — not solely a colorectal disease. As survival improves, downstream malignancy patterns change. In the UK, we have strong surveillance frameworks — but evolving international data like this should prompt reflection on whether our current upper GI strategies are optimally calibrated. For colleagues managing FAP patients: Do you feel our gastric surveillance protocols are proportionate to emerging risk? #Gastroenterology #HereditaryCancer #FAP #Endoscopy #ColorectalCancer #CancerPrevention
15 March 2026
linkedin.com
What are Dr. Udit Mittal's reviews like?
Dr. Udit Mittal's overall patient rating is 4.98 out of 5 stars on Doctify. This is based on 72 reviews.
What languages does Dr. Udit Mittal speak?
Dr. Udit Mittal speaks English and Hindi
Where is Dr. Udit Mittal located?
Dr. Udit Mittal primarily practices at Nuffield Health The Manor Hospital Oxford, located at Beech Road, Headington, United Kingdom, OX3 7RP
See more locations
Does Dr. Udit Mittal accept new patients?
Dr. Udit Mittal generally accepts new patients.
Get in touch with this specialist to enquire as a new patient